In 2017 there will be an estimated 403 thousand diagnosed incident cases of pancreatic cancer worldwide.

The number of diagnosed incident cases of pancreatic cancer worldwide will increase by 37% over the period 2017-2027.

The number of diagnosed incident cases of pancreatic cancer in 2017 is greatest in the lower-income countries of the Asia-Pacific region, accounting for 36% of the global total.

Growth in the number of diagnosed incident cases will be greater across lower- income countries at 54% over the period 2017-2027, compared to 21% across high-income countries over the same period.

There is a substantial difference in the risk of pancreatic cancer between high- income and lower-income countries, at 18 per 100,000 per year across the former and 5 per 100,000 per year across the latter.

How Glympse Bio oversubscribed their Series B funding amidst the pandemic

View Now